| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| James Peyer | 10% Owner | 2025-12-09 | 395 | $6.40 | $2.53kBuy |
| James Peyer | 10% Owner | 2025-12-09 | 446 | $7.92 | $3.53kSell |
| Cambrian Biopharma Inc | 10% Owner | 2025-12-09 | 3,105 | $8.59 | $26.67kSell |
| Cambrian Biopharma Inc | 10% Owner | 2025-12-09 | 2,666 | $7.95 | $21.19kSell |
| Cambrian Biopharma Inc | 10% Owner | 2025-12-09 | 395 | $6.40 | $2.53kBuy |
| Cambrian Biopharma Inc | 10% Owner | 2025-12-09 | 395 | $8.04 | $3.18kSell |
| Cambrian Biopharma Inc | 10% Owner | 2025-12-09 | 446 | $7.92 | $3.53kSell |
| James Peyer | 10% Owner | 2025-12-09 | 2,666 | $7.95 | $21.19kSell |
| James Peyer | 10% Owner | 2025-12-09 | 395 | $8.04 | $3.18kSell |
| James Peyer | 10% Owner | 2025-12-08 | 3,105 | $8.59 | $26.67kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James Peyer | 398.68% | 5,343,479 | $139.04M | Insider |
| Hs Investments I LP | 330.23% | 4,425,998 | $115.16M | Insider |
| Thomas G. Ricks | 51.16% | 685,632 | $17.84M | Insider |
| Cambrian Biopharma Inc | 11.58% | 155,142 | $4.04M | Insider |
| John Celebi | 7.90% | 105,862 | $2.75M | Insider |
| Robert Hamilton Pierce | 7.05% | 94,463 | $2.46M | Insider |
| Erin Colgan | 5.03% | 67,462 | $1.76M | Insider |
| Der Horst Edward Van | 4.46% | 59,794 | $1.56M | Insider |
| Patrick Stephen Gallagher | 2.55% | 34,130 | $888.06k | Insider |
| Bob Holmen | 1.91% | 25,598 | $666.06k | Insider |